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Abstract 
A systematic rev1ew was conducted to evaluate the effectiveness of vaccination to reduce 
Salmonella prevalence in market weight finisher swine To identify relevant studies, online 
databases and selected conference proceed1ngs were searched. Two reviewers independently 
assessed the relevance screening and methodological quality of studies Data of characteristics of 
study population, 1ntervent1on, outcome, stat1st1cal analys1s, and results were extracted Four 
clinical trials and 21 challenge studies were 1dent1fied for the fina l review as they described 
vaccination to reduce Salmonella in swine Present evidence suggests that vaccmat1on IS 
associated w1lh reduced Salmonella prevalence 1n sw1ne 
Introduction 
Salmonella 1s cons1dered one of the maJOr foodborne pathogens transmitted by pork and pork 
products Vaccination is considered one method of reduc1ng pre-harvest Salmonella prevalence 1n 
swine The a1m of th1s systematic rev1ew was to appra1se and synthesize studies describing 
vaccination as a method of reducing Salmonella prevalence in market weight fimsher swme (Cook 
etal, 1997, Sargeantetal , 2005) 
Materials and Methods 
The review question was "What is the association between Salmonella prevalence in the ante-
mortem or post-mortem animal ano vacc1nat1on agamst Salmonella 1n market we1ght fin1sher 
swine? A comprehensive literature search was conducted on online bibliographic databases 
Three maJor conference proceedings were searched by hand No language or publication 
restrictions for the searches were 1mposed lnclus1on criteria for relevance screemng were 1) 
pnmary research 1n English 2) Ph D theses 1n English, 3) Citations from conference proceedings, 
4) descnbed evaluation of vaccmat1on agamst Salmonella in swine m a challenge tnal or clm1cal 
tnal and 5) reported ante-mortem or post-mortem presence of Salmonella in swine The 
methodological quality of all relevant studies was independently assessed by two rev1ewers usmg 
chec fists to assess challenge trials and clm1cal tnals Methodological grades of low/high were 
assigned based on the quality criteria Components of the quality assessment included objectives 
and study population intervention withdrawals and loss to follow-up, outcome assessment and 
data analys1s Data extraction mcluded the characteristics of population mtervent1on and level of 
allocat1on to treatment groups outcome. and results Only outcome5 describing ante-mortem or 
post-mortem culture of Salmonella post-vaccmat1on were extracted 
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Results 
Four clinical trials and 21 challenge studies that reported vacc1nation against Salmonella 1n swine 
were Identified for the final rev1ew. (Baum et al. , 1997; Charles et al. , 1999; Charles et al. , 2000a; 
Charles et al. , 2000b; Coe et al. , 1992; Draayer, 1986; Foster et al. , 2003; Gibson et al. , 1999; 
Gronmga et al. , 2000; Hanna et al. , 1979; Kennedy et al. , 1999; Kern, 1994; Kolb et al. , 2001 ; Kolb 
et al. , 2002; Kramer et al. , 1987; Kramer et al , 1992; Letellier et al. , 2000; Lumsden et al. , 1991 ; 
Maes et al. , 2001 ; Neubauer and Roof, 2005; Roesler et al. , 2004b; Roesler et al. , 2004a; Roof 
and Do1tchinoff, 1995; Spnnger et al. , 2001 ). Out of 25 studies, 18 and two studies were conducted 
m the USA and Canada, respectively, and five studies were conducted m Europe All four chn1cal 
trials reported isolat1on of Salmonella 1n market we1ght finisher swine, though received a low 
methodological quality grade All the challenge studies were conducted on age less than 15-week-
old pigs while four of them received a high methodological quality grade. 
Discussion 
The majonty of studies reported a reduct1on in Salmonella assoc1ated with vaccmation using a 
variety of outcomes such as number of Salmonella pos1t1ve pigs or number of Salmonella pos1tive 
environmental samples. Some studies did not provide any data on the outcome effect other than a 
p value Most of the studies did not report study features which reduce b1as and mcrease mternal 
valid1ty, 1.e. random allocat1on of treatment un~ts or blinding at outcome assessment. Not all the 
studies tested for Salmonella status prior to the mtervention. 
Conclusion 
The present evidence suggests that vacc1nat1on against Salmonella IS assoc1ated w1th reduced 
level of Salmonella prevalence in fin~sher swme. However, many of the studies 1n the rev1ew d1d 
not to include Information that would have increased the evidentiary value of the papers 1n 
answenng the rev1ew quest1on. 
References 
Baum DH, Harris DL, Roof MB, Nielsen B. Holck JT. Polson DP, and Ba1k J. 1997 Use of SC54 for 
the reduction of Salmonella 1n swine. In: Proceedings of the Second International Symposium on 
Ep1dem1ology and Control of Salmonella 1n Pork, Copenhagen, Denmark. p 215-220 
Charles S, Trigo E. Setlje T, Abraham A, and Johnson P 1999. Evaluation of a cya (crp-cdt) 
Salmonella choleraesws commerc1al vaccine to protect against clinical signs caused by and 
reduce shedding of Salmonella typhtmunum 1n p1gs. ln. Proceedings of the 3rd International 
Sympos1um on the Epidemiology and Control of Salmonella 1n Pork, Washington, DC. p 293-295. 
Charles SO, Abraham AS, Tngo ET, Jones GF, and Settje TL 2000a Reduced shedding and 
clinical s1gns of Salmonella typhtmurium 1n nursery pigs vaccinated with a Salmonella choleraesuis 
vaccine Swine Health Pro 8·107-112. 
Charles S, Trigo E, Settje T, Blaha T, Gibson K, and Frank R. 2000b. Evaluation of cross 
protection afforded by a cya (crp-cdt) Salmonella choleraesuis commercial vaccine against 
Salmonella typhtmun·um infection in pigs In: Proceedmgs of 31st Annual Meet1ng of American 
Assoc1allon of Swme Practitioners, Indianapolis, Indiana, USA p 105-106 
Coe NE, Frank DE. Wood RL, and Roth JA 1992 Alteration of neutrophil function in BCG-treated 
and non-treated sw1ne after exposure to Salmonella typhtmunum Vet lmmunol lmmunopathol 
33:37-50 
Cook OJ, Mulrow CD, and Haynes RB 1997 Systematic reviews synthesis of best ev1dence for 
clin1cal dec1s1ons Ann Intern Med 126 376-380 
284 ., fopork 2007 Verona (ltnly) 
Draayer HA. 1986. Protecting weanling pigs against salmonellosis. Vet Med776-777. 
Foster N, Lovell MA, Marston KL, Hulme SO, Frost AJ, Bland P, and Barrow PA. 2003. Rapid 
protection of gnotobiotic pigs against experimental salmonellosis following induction of 
polymorphonuclear leukocytes by avirulent Salmonella enterica. Infect lmmun 71 :2182-2191 . 
Gibson KJ, Blaha T, Frank RK, Charles SO, and Trigo E. 1999. Investigation mto the capability of a 
Salmonella cholerasuis live vaccine to reduce the shedding of Salmonella typhtmurium in sw1ne. In: 
Bahson PB, editor. Proceedings of the 3rd International Symposium on the Epidemiology and 
Control of Salmonella in Pork. p 302-304. 
Gromnga KJ, Spnnger E, Braunschmidt M, and Pankratz D. 2000. Salmonella derby cross-
protection study. Vet Ther 1:59-63. 
Hanna J, McCracken R, and O'Brien JJ. 1979. Evaluation of a live Salmonella choleraesuis 
vaccme by intranasal challenge Res Vet Sci 26:216-219. 
Kennedy MJ, Yancey RJ, Jr., Sanchez MS. Rzepkowski RA, Kelly SM. and Curtiss Rl. 1999. 
Attenuation and immunogenicity of Deltacya Deltacrp derivatives of Salmonella choleraesuis in 
pigs. Infect lmmun 67:4628-4636. 
Kern D 1994 Duration of 1mmumty to Salmonella cholereasuis using SC-54. In: Proceedings of 
25th Amencan Association of Swine Practitioners, Chicago, lllino1s, USA. p 29-33. 
Kolb J, Roof M, and Burkhart K. 2001 . Reduction of Salmonella cholerasuis contamination in pork 
carcasses by vaccmation. In: Proceedings of 5th International Symposium on the Ep1dem1ology 
and Control of Foodbome Pathogens in Pork, Heraklion-Crete, Greece. p 210-212. 
Kolb J, Roof M, and Burkhart K 2002. Reduction of Salmonella in carcasses usmg Enterisol SC-54 
vaccmallon. In· Proceedings of 17th International Pig Vetennary Society Congress, Ames, Iowa, 
USA. p 14. 
Kramer TT, Pardon P, Marly J, and BernardS. 1987. Conjunctival and Intramuscular vaccination of 
p1gs with a live avirulent strain of Salmonella choleraesuis. Am J Vet Res 48 1072-1076. 
Kramer TT, Roof MB, and Matheson RR 1992. Safety and efficacy of an attenuated stra1n of 
Salmonella choleraesws for vacc1nation of swme. Am J Vet Res 53:444-448. 
Letell1er A, Mess1er S, Lessard L, <md Quessy S. 2000 Assessment of various treatments to 
reduce carriage of Salmonella in swine. Can J Vet Res 64:27-31 
Lumsden JS, Wilkie BN, and Clarke RC 1991 Resistance to fecal shedding of salmonellae in p1gs 
and ch1ckens vaccmated w1th an aromatic-dependent mutant of Salmonella typhtmunum. Am J Vet 
Res 52 1784-1787 
Maes D. Gibson K, Trigo E. Saszak A, Grass J, Carlson A, and Blaha T 2001 Evaluation of cross-
protection afforded by a Salmonella choleraesuis vacc1ne against Salmonella infections in pigs 
under field conditions. Berl Munch Tierarztl Wschr 114:339-341 . 
Neubauer A, and Roof MB 2005 Enterisol SC-54 cross-protection against a virulent S 
typhimurium stram In Proceedmgs of American Assoc1at1on of Swme Vetennanan, Kansas C1ty, 
M1ssoun. USA p 245-248 
Roesler U Heller P Altrock T, Arnold T Lehmann J, Waldmann KH, Truyen U, and Hansel A. 
2004a Reduct1on of Salmonella by vacc1nat1on of sows using herd-specific inactivated vaccines 
but not by antibiOtiC treatment. In Proceedings of 18th lntemat1onal P1g Vetennary Soc1ety 
Congress Hamberg, Germany p 666 
S s1on 4 Cont•ol str teg1cs Sofcpo~ 2007 -Verona (Italy 285 
Roesler U, Marg H, Schroder I, Mauer S, Arnold T, Lehmann J, Truyen U, and Hensel A. 2004b 
Oral vaccination of p1gs w1th an 1nvas1ve gyrA-cpxA-rpoB Salmonella typh1murium mutant. Vaccme 
23.595-603. 
Roof MB, and Do1tchmoff DO. 1995. Safety, Efficacy, and Durat1on of lmmun1ty Induced in Sw1ne 
by Use of An Avirulent L1ve Salmonella choleraesuis-Contaming Vaccine. Am J Vet Res 56:39-44. 
Sargeant JM, Raj1c A, Amezcua MDR, and Waddell L. 2005. A gUide to conducting systematic 
reviews m agri-food public health. In: http://www.fsrrn.net. 
Spnnger S, Lindner T, Stembach G, and Selbitz HJ. 2001 . Investigation of the efficacy of a 
genetically-stabile live Salmonella typh1murium vaccme for use 1n swine. Berl Munch Tierarztl 
Wschr 114:342-345 
286 , fcpork 2007 V ron (ltnly) 
